These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 39068400)

  • 1. "Re-evaluation of variants of uncertain significance in patients with hereditary arrhythmogenic disorders".
    Martin S; Jenewein T; Geisen C; Scheiper-Welling S; Kauferstein S
    BMC Cardiovasc Disord; 2024 Jul; 24(1):390. PubMed ID: 39068400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant classification changes over time in the clinical molecular diagnostic laboratory setting.
    Hahn E; Mighton C; Fisher Y; Wong A; Di Gioacchino V; Watkins N; Mayers J; Bombard Y; Charames GS; Lerner-Ellis J
    J Med Genet; 2024 Jul; 61(8):788-793. PubMed ID: 38806232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reclassification of Variants of Uncertain Significance in Children with Inherited Arrhythmia Syndromes is Predicted by Clinical Factors.
    Bennett JS; Bernhardt M; McBride KL; Reshmi SC; Zmuda E; Kertesz NJ; Garg V; Fitzgerald-Butt S; Kamp AN
    Pediatr Cardiol; 2019 Dec; 40(8):1679-1687. PubMed ID: 31535183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study.
    Glazer AM; Davogustto G; Shaffer CM; Vanoye CG; Desai RR; Farber-Eger EH; Dikilitas O; Shang N; Pacheco JA; Yang T; Muhammad A; Mosley JD; Van Driest SL; Wells QS; Shaffer LL; Kalash OR; Wada Y; Bland HT; Yoneda ZT; Mitchell DW; Kroncke BM; Kullo IJ; Jarvik GP; Gordon AS; Larson EB; Manolio TA; Mirshahi T; Luo JZ; Schaid D; Namjou B; Alsaied T; Singh R; Singhal A; Liu C; Weng C; Hripcsak G; Ralston JD; McNally EM; Chung WK; Carrell DS; Leppig KA; Hakonarson H; Sleiman P; Sohn S; Glessner J; ; Denny J; Wei WQ; George AL; Shoemaker MB; Roden DM
    Circulation; 2022 Mar; 145(12):877-891. PubMed ID: 34930020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of gene variant reclassification and its impact on clinical management in the inherited arrhythmia clinic.
    Young WJ; Maung S; Ahmet S; Kirkby C; Ives C; Schilling RJ; Lowe M; Lambiase PD
    Heart Rhythm; 2024 Jun; 21(6):903-910. PubMed ID: 38218330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
    So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J
    Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay.
    Hu C; Susswein LR; Roberts ME; Yang H; Marshall ML; Hiraki S; Berkofsky-Fessler W; Gupta S; Shen W; Dunn CA; Huang H; Na J; Domchek SM; Yadav S; Monteiro ANA; Polley EC; Hart SN; Hruska KS; Couch FJ
    Clin Cancer Res; 2022 Sep; 28(17):3742-3751. PubMed ID: 35736817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.
    Mersch J; Brown N; Pirzadeh-Miller S; Mundt E; Cox HC; Brown K; Aston M; Esterling L; Manley S; Ross T
    JAMA; 2018 Sep; 320(12):1266-1274. PubMed ID: 30264118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reanalysis of eMERGE phase III sequence variants in 10,500 participants and infrastructure to support the automated return of knowledge updates.
    Zouk H; Yu W; Oza A; Hawley M; Vijay Kumar PK; Koch C; Mahanta LM; Harley JB; Jarvik GP; Karlson EW; Leppig KA; Myers MF; Prows CA; Williams MS; Weiss ST; Lebo MS; Rehm HL
    Genet Med; 2022 Feb; 24(2):454-462. PubMed ID: 34906510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing using microfluidic PCR enrichment for molecular autopsy.
    Raju H; Ware JS; Skinner JR; Hedley PL; Arno G; Love DR; van der Werf C; Tfelt-Hansen J; Winkel BG; Cohen MC; Li X; John S; Sharma S; Jeffery S; Wilde AAM; Christiansen M; Sheppard MN; Behr ER
    BMC Cardiovasc Disord; 2019 Jul; 19(1):174. PubMed ID: 31337358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance.
    Tsai GJ; Rañola JMO; Smith C; Garrett LT; Bergquist T; Casadei S; Bowen DJ; Shirts BH
    Genet Med; 2019 Jun; 21(6):1435-1442. PubMed ID: 30374176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Myocardial Fibrosis as an Alternative Phenotype Pathway of Inherited Cardiac Structural Disorders.
    Junttila MJ; Holmström L; Pylkäs K; Mantere T; Kaikkonen K; Porvari K; Kortelainen ML; Pakanen L; Kerkelä R; Myerburg RJ; Huikuri HV
    Circulation; 2018 Jun; 137(25):2716-2726. PubMed ID: 29915098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants.
    Kim JJ; Kim DJ; Nam EJ; Song KE; Ham JY; Kim YK; Lee NY
    Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Variant Reclassification in Cancer Predisposition Genes on Clinical Care.
    Chiang J; Chia TH; Yuen J; Shaw T; Li ST; Binte Ishak ND; Chew EL; Chong ST; Chan SH; Ngeow J
    JCO Precis Oncol; 2021 Nov; 5():577-584. PubMed ID: 34994607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
    Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
    Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular autopsy of sudden unexplained deaths reveals genetic predispositions for cardiac diseases among young forensic cases.
    Hellenthal N; Gaertner-Rommel A; Klauke B; Paluszkiewicz L; Stuhr M; Kerner T; Farr M; Püschel K; Milting H
    Europace; 2017 Nov; 19(11):1881-1890. PubMed ID: 29016939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reanalysis and reclassification of rare genetic variants associated with inherited arrhythmogenic syndromes.
    Campuzano O; Sarquella-Brugada G; Fernandez-Falgueras A; Coll M; Iglesias A; Ferrer-Costa C; Cesar S; Arbelo E; García-Álvarez A; Jordà P; Toro R; Tiron de Llano C; Grassi S; Oliva A; Brugada J; Brugada R
    EBioMedicine; 2020 Apr; 54():102732. PubMed ID: 32268277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of VUS reclassification in a single-centre series from application of ACMG/AMP classification rules specified for
    Innella G; Ferrari S; Miccoli S; Luppi E; Fortuno C; Parsons MT; Spurdle AB; Turchetti D
    J Med Genet; 2024 Apr; 61(5):483-489. PubMed ID: 38160042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next generation sequencing in a young population with suspected inherited malignant cardiac arrhythmias.
    Broendberg AK; Christiansen MK; Nielsen JC; Pedersen LN; Jensen HK
    Eur J Hum Genet; 2018 Mar; 26(3):303-313. PubMed ID: 29343803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.